Search

everythinglearnresearchcommunity

for

Search:↓

Different types of polycystic ovary syndrome (PCOS) have varying severity, with Type I being the most severe and common.

Baldness caused by male hormones in female-to-male transsexuals doesn't increase the risk of heart disease.

Metformin has limited effectiveness for improving PCOS symptoms and lacks clear benefits, needing more research to confirm its efficacy.

Finasteride caused long-term sexual and non-sexual side effects in young men with hair loss.

Exercise improves insulin sensitivity and hormone regulation in PCOS rats.

Coffee and tea might help hair growth in balding individuals, but side effects and alternative uses are being considered.

Hair transplantation is a treatment for hair loss mainly caused by genetics, with various techniques and potential complications, and results visible after 8-12 months.

The polyherbal hair serum helped prevent hair loss and improved hair growth better than the usual treatment.

Removing a testicular tumor in a dog reduced its aggressive behavior and skin problems.

Male hormones may play a role in the development of heart disease, and more research is needed to understand their effects.

Polycystic Ovary Syndrome likely starts in childhood and may be genetic and influenced by early hormone exposure.

Hirsutism is more linked to high androgen levels than acne or hair loss, and a mix of hormonal tests is best for diagnosis; certain treatments can reduce symptoms.

Finasteride reduces hair growth better, but spironolactone has more side effects.

Finasteride is a safe, effective treatment for hirsutism with fewer side effects.

Androgens cause skin issues like acne and hair growth in women, often due to PCOS, and can be treated with medication and lifestyle changes.

The conclusion is that published guidelines are improving transgender medical care, but more research and education in transgender medicine are needed.

Cuscuta reflexa extract may help treat hair loss caused by hormones.

Hair sensitivity to androgens is partly controlled by specific enzyme expressions in different hair areas.

The document concludes that targeting 5α-reductase, the androgen receptor, and hair growth genes, along with using compounds with anti-androgenic properties, could lead to more effective hair loss treatments.

Dihydrotestosterone increases the activity of an enzyme in pubic skin cells that converts testosterone to dihydrotestosterone.

Different women's hair and skin glands respond to hormones in varied ways, which can cause unwanted hair growth even with normal hormone levels, and more research is needed to treat this effectively.

Men with male-pattern baldness have more androgen receptors in their scalp's oil glands, which may contribute to hair loss.

Men are more likely to get infectious skin diseases, while women are more prone to autoimmune and pigment-related skin conditions, influenced by biological and environmental factors.

Some herbs and their components might help treat hair loss by affecting various biological pathways, but more research and regulation are needed.

Metformin and rosiglitazone both improved insulin use and hormonal symptoms in women with PCOS.

Insulin-lowering medications show promise for PCOS symptoms but can't be the main treatment yet due to limited long-term research.

Finasteride and flutamide effectively reduce hirsutism in PCOS women, with flutamide also lowering hormone levels.

Androgen Deprivation Therapy for prostate cancer often reduces sexual function but intermittent therapy may be more tolerable.

Hormone therapy affects hair growth in transgender individuals, with testosterone potentially causing hair loss in trans men and estrogen reducing facial/body hair in trans women; treatment options vary.

Women with polycystic ovary syndrome tend to have a longer anogenital distance.